Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision

被引:14
|
作者
Jiang, Wei [1 ]
Zhao, Bingqing [2 ]
Li, Yongcheng [3 ]
Qi, Dunfeng [4 ]
Wang, Daxing [5 ]
机构
[1] Tianjin First Cent Hosp, Dept Gen Surg, Tianjin 300192, Peoples R China
[2] Tianjin Second Peoples Hosp, Dept Surg, Tianjin 300192, Peoples R China
[3] Southeast Univ, Xuzhou Cent Hosp, Dept Med Oncol, Affiliated Xuzhou Hosp,Med Coll, Xuzhou 221009, Jiangsu, Peoples R China
[4] Southeast Univ, Xuzhou Cent Hosp, Dept Hepat Biliary Pancreat Splen Surg, Affiliated Xuzhou Hosp,Med Coll, Xuzhou 221009, Jiangsu, Peoples R China
[5] Peoples Hosp Huaiyin Jinan, Dept Gen Surg, Jinan 250021, Peoples R China
关键词
Gallbladder carcinoma; SEER; Overall survival; AJCC; Stage; Prognosis; IMPACT;
D O I
10.1186/s12885-020-07578-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe 8th edition of the American Joint Committee on Cancer (AJCC) staging system for gallbladder carcinoma (GBC) came into force since 2018. However, the prognostic precision of this staging system has not been properly assessed. This study aimed to evaluate the latest staging system and suggest modifications to improve its prognostic precision.MethodsData of patients with GBC was included from the Surveillance, Epidemiology and End Results (SEER) database (2004-2015) and multicenter database (2010-2017). Baseline clinicopathologic characteristics were recorded including age, sex, race, grade, T category, N category, M category and stage. The Kaplan-Meier method was used to plot survival functions. The prediction power of the AJCC 8th edition and its modified version were evaluated using the concordance index (C-index).ResultsA total of 2779 GBC patients were included in the SEER database and 591 were collected from multicenter database. While no significant difference in survival of patients was observed between stages IVA and IVB using the 8th AJCC staging system (p>0.05), the prognosis of stage IIIA showed a slightly better outcome than stage IIIB (p=0.046) in the SEER database. In the multicenter database, there was no significant difference between stage IIIA and stage IIIB (p>0.05). Similarly, no significant difference in the survival of patients between stages IIIA and IIIB was observed when M0 patients with at least 6 lymph nodes (LNs) were analyzed (p>0.05) for both SEER and multicenter database. On the other hand, a modified staging system was able to stratify patients from stage IIIA, stage IIIB and stage IV (p<0.001). For the SEER database, the C-indexes of 8th AJCC staging system and that of its modified version were 0.709 and 0.742, respectively. For the multicenter database, the C-index of 8th AJCC staging system and that of our modified version were 0.635 and 0.679, respectively.ConclusionsThe modified 8th staging system proposed in this study can improve the prognostic precision of the 8th AJCC staging system for GBC. We therefore suggest including these modifications in the next update of AJCC staging system for GBC.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision
    Wei Jiang
    Bingqing Zhao
    Yongcheng Li
    Dunfeng Qi
    Daxing Wang
    BMC Cancer, 20
  • [2] Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging
    Catalin Bogdan Satala
    Ioan Jung
    Laszlo Kobori
    Zsolt Kovacs
    Decebal Fodor
    Rita Szodorai
    Simona Gurzu
    Journal of Gastrointestinal Cancer, 2021, 52 : 243 - 248
  • [3] Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging
    Satala, Catalin Bogdan
    Jung, Ioan
    Kobori, Laszlo
    Kovacs, Zsolt
    Fodor, Decebal
    Szodorai, Rita
    Gurzu, Simona
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (01) : 243 - 248
  • [4] Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma
    Oweira, Hani
    Giryes, Anwar
    Mannhart, Meinrad
    Decker, Michael
    Schlumpf, Rolf
    Abdel-Rahman, Omar
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 923 - 929
  • [5] Validation of the 8th American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma
    Jun, Sun-Young
    Sung, You-Na
    Hong, Seung-Mo
    LABORATORY INVESTIGATION, 2018, 98 : 679 - 679
  • [6] Validation of the 8th American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma
    Jun, Sun-Young
    Sung, You-Na
    Hong, Seung-Mo
    MODERN PATHOLOGY, 2018, 31 : 679 - 679
  • [7] External validation of the 8th American Joint Committee on Cancer staging system for gall bladder carcinoma
    Oweira, Hari
    Mehrabi, Arianeb
    Giryes, Anwar
    Tekbas, Aysun
    Abdel-Rahman, Omar
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 1084 - 1090
  • [8] Assessment of the Prognostic Staging System of American Joint Committee on Cancer 8th Edition for Breast Cancer: Comparisons with the Conventional Anatomic Staging System
    Kim, Eun Jin
    Park, Hyung Seok
    Kim, Jee Ye
    Kim, Seung Il
    Cho, Young-Up
    Park, Byeong-Woo
    JOURNAL OF BREAST CANCER, 2020, 23 (01) : 59 - 68
  • [9] Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma
    Moeckelmann, Nikolaus
    Ebrahimi, Ardalan
    Tou, Ying K.
    Gupta, Ruta
    Low, Tsu-Hui
    Ashford, Bruce
    Ch'ng, Sydney
    Palme, Carsten E.
    Clark, Jonathan R.
    ORAL ONCOLOGY, 2018, 85 : 82 - 86
  • [10] Modified staging classification of gallbladder carcinoma on the basis of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system
    Wang, Jie
    Bo, Xiaobo
    Shi, Xiao
    Suo, Tao
    Xin, Yanlei
    Nan, Lingxi
    Wang, Changcheng
    Ni, Xiaoling
    Liu, Han
    Pan, Hongtao
    Shen, Sheng
    Li, Min
    Lu, Pinxiang
    Zhang, Dexiang
    Wang, Zhiqin
    Wang, Yueqi
    Liu, Houbao
    EJSO, 2020, 46 (04): : 527 - 533